SI1197223T1 - - Google Patents
Info
- Publication number
- SI1197223T1 SI1197223T1 SI200030651T SI200030651T SI1197223T1 SI 1197223 T1 SI1197223 T1 SI 1197223T1 SI 200030651 T SI200030651 T SI 200030651T SI 200030651 T SI200030651 T SI 200030651T SI 1197223 T1 SI1197223 T1 SI 1197223T1
- Authority
- SI
- Slovenia
- Prior art keywords
- retinopathy
- angiotensin
- treating
- salt
- development
- Prior art date
Links
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 208000017442 Retinal disease Diseases 0.000 abstract 1
- 206010038923 Retinopathy Diseases 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12149899 | 1999-04-28 | ||
| EP00921056A EP1197223B1 (en) | 1999-04-28 | 2000-04-27 | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
| PCT/JP2000/002766 WO2000066161A1 (en) | 1999-04-28 | 2000-04-27 | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1197223T1 true SI1197223T1 (enExample) | 2005-08-31 |
Family
ID=14812676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200030651T SI1197223T1 (enExample) | 1999-04-28 | 2000-04-27 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7064141B1 (enExample) |
| EP (1) | EP1197223B1 (enExample) |
| KR (1) | KR100865059B1 (enExample) |
| CN (1) | CN1172719C (enExample) |
| AT (1) | ATE289204T1 (enExample) |
| AU (1) | AU774799B2 (enExample) |
| BR (1) | BR0010084A (enExample) |
| CA (1) | CA2371554C (enExample) |
| CZ (1) | CZ301913B6 (enExample) |
| DE (1) | DE60018186T2 (enExample) |
| DK (1) | DK1197223T3 (enExample) |
| ES (1) | ES2233362T3 (enExample) |
| HU (1) | HU226948B1 (enExample) |
| MX (1) | MXPA01010923A (enExample) |
| NO (1) | NO327446B1 (enExample) |
| NZ (1) | NZ514855A (enExample) |
| PL (1) | PL196895B1 (enExample) |
| PT (1) | PT1197223E (enExample) |
| RU (1) | RU2239454C2 (enExample) |
| SI (1) | SI1197223T1 (enExample) |
| SK (1) | SK286859B6 (enExample) |
| WO (1) | WO2000066161A1 (enExample) |
| ZA (1) | ZA200108527B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4484427B2 (ja) * | 2001-12-03 | 2010-06-16 | 武田薬品工業株式会社 | インスリン抵抗性改善剤 |
| CA2468827A1 (en) * | 2001-12-03 | 2003-06-12 | Takeda Chemical Industries, Ltd. | Insulin resistance improving agents |
| TW200304812A (en) * | 2002-03-08 | 2003-10-16 | Sankyo Co | An eye drop containing a tetrazole derivative |
| US8980870B2 (en) | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
| DE10335027A1 (de) * | 2003-07-31 | 2005-02-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Angiotensin II Rezeptor Antagonisten |
| ES2535291T3 (es) * | 2003-04-15 | 2015-05-08 | Daiichi Sankyo Company, Limited | Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas |
| US20050038093A1 (en) * | 2003-05-02 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Treating diabetic retinopathy with angiotensin II receptor blockers |
| ES2425750T3 (es) | 2004-08-31 | 2013-10-17 | Newsouth Innovations Pty Limited | Inhibición del VEGF |
| PL1814527T5 (pl) * | 2004-11-05 | 2021-08-02 | Boehringer Ingelheim International Gmbh | Dwuwarstwowa tabletka zawierająca telmisartan i amlodypinę |
| RU2420280C2 (ru) * | 2005-04-21 | 2011-06-10 | Сантен Фармасьютикал Ко., Лтд | Терапевтическое средство против кератоконъюнктивального расстройства |
| KR20080074128A (ko) * | 2005-12-06 | 2008-08-12 | 산텐 세이야꾸 가부시키가이샤 | 각결막 장애 치료제 |
| TWI415634B (zh) * | 2007-03-28 | 2013-11-21 | Takeda Pharmaceutical | 固態醫藥組成物 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027211D0 (en) | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| DE4201554A1 (de) * | 1992-01-22 | 1993-07-29 | Thomae Gmbh Dr K | Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US5614519A (en) | 1991-02-06 | 1997-03-25 | Karl Thomae Gmbh | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists |
| GB9110635D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| IL104755A0 (en) * | 1992-02-17 | 1993-06-10 | Ciba Geigy Ag | Treatment of glaucoma |
| GB9223860D0 (en) * | 1992-11-13 | 1993-01-06 | Glaxo Group Ltd | Chemical compounds |
| CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
| JPH0789957A (ja) | 1993-09-22 | 1995-04-04 | Nissan Chem Ind Ltd | ビフェニルメチルアミン誘導体 |
| US5889020A (en) * | 1994-02-08 | 1999-03-30 | Ciba Vision Corporation | Treatment of normotensive glaucoma with angiotensin II antagonists |
| JPH09210183A (ja) * | 1996-01-31 | 1997-08-12 | Suzuki Motor Corp | 動力伝達装置 |
| UA49880C2 (uk) * | 1996-03-29 | 2002-10-15 | Смітклайн Бічам Корпорейшн | Дигідрат ерпоcартану, фармацевтична композиція, спосіб отримання твердої дозованої форми, спосіб блокування рецепторів ангіотензину іі |
| NZ330774A (en) * | 1996-04-05 | 1999-06-29 | Takeda Chemical Industries Ltd | Pharmaceutical composition having angiotensin ii antagonistic activity or salt thereof with an insulin-sensitivity increasing compound and postprandial hyperglycemia in diabetes mellitus and antagonistic activity and increased insulin-sensitivity |
| TW416953B (en) * | 1996-09-25 | 2001-01-01 | Takeda Chemical Industries Ltd | Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use |
| EP0855392A3 (de) | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| JP4475685B2 (ja) * | 1997-06-27 | 2010-06-09 | スミスクライン・ビーチャム・コーポレイション | エプロサルタン・一水和物 |
| IT1292437B1 (it) * | 1997-06-30 | 1999-02-08 | Zambon Spa | Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti |
| ATE341325T1 (de) * | 1997-08-06 | 2006-10-15 | Smithkline Beecham Corp | Eprosartan arginyl-ladungsneutralisationskomplex und verfahren zu dessen herstellung und verabreichung |
| WO1999044590A1 (en) | 1998-03-04 | 1999-09-10 | Takeda Chemical Industries, Ltd. | Sustained-release preparation for aii antagonist, production and use thereof |
| KR20040078140A (ko) * | 1998-07-10 | 2004-09-08 | 노파르티스 아게 | 발사르탄 및 칼슘 채널 차단제의 항고혈압 병용 제제 |
| FR2783422A1 (fr) | 1998-09-21 | 2000-03-24 | Sanofi Sa | Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire |
| JP2000159671A (ja) | 1998-12-01 | 2000-06-13 | Takeda Chem Ind Ltd | 血管新生阻害剤 |
-
2000
- 2000-04-27 CA CA002371554A patent/CA2371554C/en not_active Expired - Fee Related
- 2000-04-27 HU HU0200890A patent/HU226948B1/hu not_active IP Right Cessation
- 2000-04-27 RU RU2001132073/15A patent/RU2239454C2/ru not_active IP Right Cessation
- 2000-04-27 NZ NZ514855A patent/NZ514855A/xx not_active IP Right Cessation
- 2000-04-27 PL PL350554A patent/PL196895B1/pl not_active IP Right Cessation
- 2000-04-27 CN CNB008067783A patent/CN1172719C/zh not_active Expired - Fee Related
- 2000-04-27 ES ES00921056T patent/ES2233362T3/es not_active Expired - Lifetime
- 2000-04-27 SK SK1545-2001A patent/SK286859B6/sk not_active IP Right Cessation
- 2000-04-27 PT PT00921056T patent/PT1197223E/pt unknown
- 2000-04-27 AU AU41434/00A patent/AU774799B2/en not_active Ceased
- 2000-04-27 MX MXPA01010923A patent/MXPA01010923A/es active IP Right Grant
- 2000-04-27 US US09/958,740 patent/US7064141B1/en not_active Expired - Fee Related
- 2000-04-27 AT AT00921056T patent/ATE289204T1/de not_active IP Right Cessation
- 2000-04-27 EP EP00921056A patent/EP1197223B1/en not_active Expired - Lifetime
- 2000-04-27 BR BR0010084-6A patent/BR0010084A/pt not_active Application Discontinuation
- 2000-04-27 WO PCT/JP2000/002766 patent/WO2000066161A1/ja not_active Ceased
- 2000-04-27 DE DE60018186T patent/DE60018186T2/de not_active Expired - Lifetime
- 2000-04-27 KR KR1020017013765A patent/KR100865059B1/ko not_active Expired - Fee Related
- 2000-04-27 SI SI200030651T patent/SI1197223T1/xx unknown
- 2000-04-27 DK DK00921056T patent/DK1197223T3/da active
- 2000-04-27 CZ CZ20013804A patent/CZ301913B6/cs not_active IP Right Cessation
-
2001
- 2001-10-17 ZA ZA200108527A patent/ZA200108527B/en unknown
- 2001-10-26 NO NO20015257A patent/NO327446B1/no not_active IP Right Cessation
-
2006
- 2006-04-19 US US11/406,345 patent/US20060189669A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9801690D0 (en) | Therapeutic agents | |
| MY134880A (en) | Thiazolyl amide derivatives | |
| AU2864002A (en) | Compounds having fungicidal activity and processes to make and use same | |
| DE60111734D1 (de) | [1,4']-bipiperidin verbindungen | |
| ATE293609T1 (de) | Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität | |
| ZA922527B (en) | Remedies for bone diseases | |
| IL158735A0 (en) | Novel ligand for nicotinic acetylcholine receptors useful in therapy | |
| HUP0101958A3 (en) | Enhancement oxazolidinone antibacterial agents activity by using arginine derivatives | |
| ATE248822T1 (de) | Partikel mit kontrollierter freisetzungsrate | |
| PL350554A1 (en) | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy | |
| WO2001041751A8 (en) | Phytoestrogens for treating als | |
| ZA9811715B (en) | Aqueous insecticidal pour-on treatment. | |
| TR199901017A2 (xx) | B�cek ilac� terkibi. | |
| MXPA02005011A (es) | Nuevos derivados de tiazolidindiona como agentes antidiabeticos. | |
| PT896822E (pt) | 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y | |
| SI1619185T1 (sl) | 4,4-difluoro-1,2,3,4-tetrahidro-5H-1-benzazepinski derivat ali njegova sol | |
| MXPA03009209A (es) | Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos. | |
| PT1027891E (pt) | Antagonista de neuropeptido y | |
| WO2001011968A3 (en) | Heterocyclic spiro compounds as pesticides | |
| SI1086695T1 (en) | Antiviral compositions comprising yohimbine as active principle | |
| MXPA05009243A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados. | |
| MXPA04000581A (es) | Derivados de 2 -(aminometil) -tetrahidro-9 -oxa-1, 3-diaza-ciclopenta [a] -naftalenilo con actividad antipsicotica. | |
| EP1118327A4 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS. | |
| PL372997A1 (en) | 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action | |
| AU2003224881A8 (en) | Antimicrobial compounds against staphylococci, mycobacteria, and other infectious agents |